Adial Pharmaceuticals Inc: Believes Existing Cash & Cash Equivalents to Fund Its Operating Expenses Into H2 2025
Adial Pharmaceuticals Inc:相信現有的現金和現金等價物可以支持其營業費用到2025年下半年。
Adial Pharmaceuticals Inc: Believes Existing Cash & Cash Equivalents to Fund Its Operating Expenses Into H2 2025
Adial Pharmaceuticals Inc:相信現有的現金和現金等價物可以支持其營業費用到2025年下半年。
譯文內容由第三人軟體翻譯。